Siderophores in Iron Metabolism: From Mechanism to Therapy Potential

Trends in Molecular Medicine

Volumn 22, Issue 12, 2016, Pages 1077-1090

  Wilson, Briana R ^a   Bogdan, Alexander R ^a   Miyazawa, Masaki ^a   Hashimoto, Kazunori ^a   Tsuji, Yoshiaki ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

hypoxia; iron; Lcn2; mitophagy; siderocalin; siderophore

Indexed keywords

PARKIN; SIDEROPHORE; TOLL LIKE RECEPTOR 4; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

BACTERIAL INFECTION; DRUG ELIMINATION; DRUG MECHANISM; HOSPITAL INFECTION; IRON METABOLISM; MITOPHAGY; NONHUMAN; REVIEW; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; DRUG DEVELOPMENT; DRUG EFFECTS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DISCOVERY; HOST-PATHOGEN INTERACTIONS; HUMANS; IRON; LIPOCALIN-2; SIDEROPHORES;

EID: 84999670122     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2016.10.005     Document Type: Review

References (71)

1. 1 Magill, S.S., et al. Multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 370 (2014), 1198–1208.
2. 2 Temkin, E., et al. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann. N. Y. Acad. Sci. 1323 (2014), 22–42.
3. 3 Soares, M.P., Weiss, G., The Iron Age of host–microbe interactions. EMBO Rep. 16 (2015), 1482–1500.
4. 4 Holden, V.I., Bachman, M.A., Diverging roles of bacterial siderophores during infection. Metallomics. 7 (2015), 986–995.
5. 5 Peleg, A.Y., et al. The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One, 7, 2012, e46984.
6. 6 Harrison, F., Buckling, A., Siderophore production and biofilm formation as linked social traits. ISME J. 3 (2009), 632–634.
7. 7 Gaddy, J.A., et al. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 80 (2012), 1015–1024.
8. 8 Marti, S., et al. Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS One, 6, 2011, e26030.
9. 9 Morris, J.J., Black Queen evolution: the role of leakiness in structuring microbial communities. Trends Genet. 31 (2015), 475–482.
10. 10 Su, H.C., et al. The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins. Antimicrob. Agents Chemother. 54 (2010), 4626–4635.
11. 11 Tseng, B.S., et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ. Microbiol. 15 (2013), 2865–2878.
12. 12 Bogdan, A.R., et al. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem. Sci. 41 (2016), 274–286.
13. 13 Chakraborty, S., et al. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta. 1826 (2012), 129–169.
14. 14 Sydnor, E.R., Perl, T.M., Hospital epidemiology and infection control in acute-care settings. Clin. Microbiol. Rev. 24 (2011), 141–173.
15. 15 Hider, R.C., Kong, X., Chemistry and biology of siderophores. Nat. Prod. Rep. 27 (2010), 637–657.
16. 16 Schalk, I.J., Guillon, L., Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways. Amino Acids 44 (2013), 1267–1277.
17. 17 Allen, G.F., et al. Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 14 (2013), 1127–1135.
18. 18 Nagi, M., et al. Iron-depletion promotes mitophagy to maintain mitochondrial integrity in pathogenic yeast Candida glabrata. Autophagy 12 (2016), 1259–1271.
19. 19 Schiavi, A., et al. Iron-starvation-induced mitophagy mediates lifespan extension upon mitochondrial stress in C. elegans. Curr. Biol. 25 (2015), 1810–1822.
20. 20 Kirienko, N.V., et al. Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death. Cell Host Microbe 13 (2013), 406–416.
21. 21 Kirienko, N.V., et al. Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 1821–1826.
22. 22 Pickrell, A.M., Youle, R.J., The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85 (2015), 257–273.
23. 23 Hartmann, H., et al. Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology 134 (2008), 756–767.
24. 24 Holden, V.I., et al. Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1alpha and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect. Immun. 82 (2014), 3826–3836.
25. 25 Koh, M.Y., Powis, G., Passing the baton: the HIF switch. Trends Biochem. Sci. 37 (2012), 364–372.
26. 26 Palazon, A., et al. HIF transcription factors, inflammation, and immunity. Immunity 41 (2014), 518–528.
27. 27 Peyssonnaux, C., et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115 (2005), 1806–1815.
28. 28 Anand, R.J., et al. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J. Leukoc. Biol. 82 (2007), 1257–1265.
29. 29 Elks, P.M., et al. Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism. PLoS Pathog., 9, 2013, e1003789.
30. 30 Nairz, M., et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210 (2013), 855–873.
31. 31 Wessling-Resnick, M., Iron homeostasis and the inflammatory response. Annu. Rev. Nutr. 30 (2010), 105–122.
32. 32 Oexle, H., et al. Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 74 (2003), 287–294.
33. 33 Chandrasekar, B.S., et al. Interferon-gamma and nitric oxide synthase 2 mediate the aggregation of resident adherent peritoneal exudate cells: implications for the host response to pathogens. PLoS One, 10, 2015, e0128301.
34. 34 Michels, K., et al. Hepcidin and host defense against infectious diseases. PLoS Pathog., 11, 2015, e1004998.
35. 35 Kim, D.K., et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20 (2014), 419–424.
36. 36 Pilonieta, M.C., et al. Salmonella enterica infection stimulates macrophages to hemophagocytose. MBio., 5, 2014, e02211.
37. 37 McDonald, E.M., et al. Bacterial stimulation of Toll-like receptor 4 drives macrophages to hemophagocytose. Infect. Immun. 84 (2016), 47–55.
38. 38 McCoy, M.W., et al. Hemophagocytic macrophages in murine typhoid fever have an anti-inflammatory phenotype. Infect. Immun. 80 (2012), 3642–3649.
39. 39 Peyssonnaux, C., et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107 (2006), 3727–3732.
40. 40 Worthington, R.J., Melander, C., Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 31 (2013), 177–184.
41. 41 Deak, D., et al. Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015. Ann. Intern. Med. 165 (2016), 363–372.
42. 42 Winstanley, C., et al. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24 (2016), 327–337.
43. 43 Baldoni, D., et al. In vitro activity of gallium maltolate against staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Antimicrob. Agents Chemother. 54 (2010), 157–163.
44. 44 Antunes, L.C., et al. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 56 (2012), 5961–5970.
45. 45 Lui, G.Y., et al. Targeting cancer by binding iron: dissecting cellular signaling pathways. Oncotarget 6 (2015), 18748–18779.
46. 46 Banin, E., et al. The potential of desferrioxamine–gallium as an anti-Pseudomonas therapeutic agent. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 16761–16766.
47. 47 Frangipani, E., et al. Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58 (2014), 5572–5575.
48. 48 Gorska, A., et al. Siderophore–drug complexes: potential medicinal applications of the ‘Trojan horse’ strategy. Trends Pharmacol. Sci. 35 (2014), 442–449.
49. 49 Mollmann, U., et al. Siderophores as drug delivery agents: application of the ‘Trojan Horse’ strategy. Biometals 22 (2009), 615–624.
50. 50 Coates, A.R., et al. Novel classes of antibiotics or more of the same?. Br. J. Pharmacol. 163 (2011), 184–194.
51. 51 Ito, A., et al. In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria. J. Antimicrob. Chemother. 71 (2016), 670–677.
52. 52 Ito-Horiyama, T., et al. Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases. Antimicrob. Agents Chemother. 60 (2016), 4384–4386.
53. 53 Santajit, S., Indrawattana, N., Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed. Res. Int., 2016, 2016, 2475067.
54. 54 Pages, J.M., et al. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6 (2008), 893–903.
55. 55 Sugawara, E., et al. Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa. FEBS J. 279 (2012), 910–918.
56. 56 Nguyen, L., Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch. Toxicol. 90 (2016), 1585–1604.
57. 57 Sritharan, M., Iron homeostasis in Mycobacterium tuberculosis: mechanistic insights into siderophore-mediated iron uptake. J. Bacteriol. 198 (2016), 2399–2409.
58. 58 Lun, S., et al. Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice. Antimicrob. Agents Chemother. 57 (2013), 5138–5140.
59. 59 Vasan, M., et al. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening. Chem. Med. Chem. 5 (2010), 2079–2087.
60. 60 Jones, C.M., et al. Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 1945–1950.
61. 61 Cheung, J., et al. Discovery of an iron-regulated citrate synthase in Staphylococcus aureus. Chem. Biol. 19 (2012), 1568–1578.
62. 62 Sheldon, J.R., et al. TCA cycle activity in Staphylococcus aureus is essential for iron-regulated synthesis of staphyloferrin A, but not staphyloferrin B: the benefit of a second citrate synthase. Mol. Microbiol. 92 (2014), 824–839.
63. 63 Kobylarz, M.J., et al. SbnG, a citrate synthase in Staphylococcus aureus: a new fold on an old enzyme. J. Biol. Chem. 289 (2014), 33797–33807.
64. 64 Tripathi, A., et al. Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis. J. Am. Chem. Soc. 136 (2014), 1579–1586.
65. 65 Li, C., Chan, Y.R., Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine 56 (2011), 435–441.
66. 66 Steigedal, M., et al. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. J. Immunol. 193 (2014), 6081–6089.
67. 67 Singh, V., et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun., 6, 2015, 7113.
68. 68 Bachman, M.A., et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79 (2011), 3309–3316.
69. 69 Shields-Cutler, R.R., et al. Human urinary composition controls antibacterial activity of siderocalin. J. Biol. Chem. 290 (2015), 15949–15960.
70. 70 Klebba, P.E., ROSET model of TonB action in Gram-negative bacterial iron acquisition. J. Bacteriol. 198 (2016), 1013–1021.
71. 71 Horiyama, T., Nishino, K., AcrB, AcrD, and MdtABC multidrug efflux systems are involved in enterobactin export in Escherichia coli. PLoS One, 9, 2014, e108642.